Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Redx Pharma is a drug discovery and development company.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Ovid Therapeutic's purpose is to solve intractable medical problems.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Bambusa Therapeutics operates as biotechnology company.
Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.
OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
EmployerDirect Healthcare is a supplemental healthcare benefit that directs planned medical procedures to high-quality providers.
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Redmile Group has invested in 104 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Redmile Group's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 17 different industry categories.
Among tracked funding rounds, Oruka Therapeutics received $700.4M in a Post-IPO Equity round. Redmile Group's total known invested capital is $12.5B.
Redmile Group's average investment size is $136.1M across its portfolio of 104 companies.
Recent Redmile Group portfolio additions include Krystal Biotech, Redx Pharma, Boundless Bio, Atara Biotherapeutics, Oruka Therapeutics. These companies were founded in 2020 or later.